News | May 11, 2015

Twelve Late-Breaking Clinical Trials to be Presented at Heart Rhythm 2015

Key studies that will help advance electrophysiology at HRS

May 11, 2015 — The Heart Rhythm Society (HRS) has released the list of its 12 late-breaking electrophysiology (EP) clinical trials that will be presented at Heart Rhythm 2015, which takes place May 13-16, 2015 in Boston. 
Session I: Thursday, May 14, 1:30– 3 p.m. EDT in Ballroom West?
Impact of Remote Monitoring on Clinical Events and Healthcare Utilization: A nationwide assessment
VENTURE-AF: A Randomized Global Trial Evaluating Uninterrupted Rivaroxaban and Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Nonvalvular Atrial Fibrillation
Cryoballoon Versus Open Irrigated Radiofrequency Ablation in Patients with Paroxysmal Atrial Fibrillation: The prospective, randomized controlled, non-inferiority FreezeAF Study
Botulinum Toxin Injection in Epicardial Fat Pads for Prevention of Atrial Fibrillation After Cardiac Surgery: One year follow up of randomized pilot study
Wireless LV Endocardial Stimulation for CRT: Primary results of the Safety and Performance of Electrodes implanted in the Left Ventricle (SELECT-LV) Study
The Evera MRI Study
Session II: Friday, May 15, 2015, 8–9:30 a.m. EDT in Ballroom West?
Performance of a Miniaturized Transcatheter Pacing System: First-in-human experience
Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction: Safety and Efficacy in Patients with and without Chronic Resynchronization Therapy
Canadian Registry of Cardiac Implantable Electronic Device Outcomes: Phase 1 Riata Lead on Advisory (CREDO)
Clinical Safety of the Iforia ProMRI ICD System Subjected to 1.5T Cardiac or Thoracic Spine MRI
Effect of linear ablation in substrate-based AF: Results of the Substrate Modification with Ablation and Antiarrhythmic Drugs in Nonpermanent Atrial Fibrillation trial
Visually-Guided Laser Balloon (VGLB) Pulmonary Vein Isolation For The Treatment of Paroxysmal Atrial Fibrillation (PAF): Results Of The Prospective Multicenter Randomized Heartlight Study 
For more information:

Related Content

Videos | EP Mapping and Imaging Systems

An example of the Acutus Medical AcQMap High Resolution Imaging and Mapping System to guide electrophysiology (EP) ...

Home October 14, 2021
News | EP Mapping and Imaging Systems

September 29, 2020 — The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the second-generation of ...

Home September 29, 2020
News | EP Mapping and Imaging Systems

September 14, 2020 — Philips Healthcare released new imaging and workflow enhancements for its novel Kodex-EPD cardiac ...

Home September 14, 2020
News | EP Mapping and Imaging Systems

August 17, 2020 — A Northwestern Medicine Bluhm Cardiovascular Institute physician was the first electrophyiologist in ...

Home August 17, 2020
News | EP Mapping and Imaging Systems

October 15, 2019 — Kardium Inc. announced that the Globe mapping and ablation system has successfully demonstrated ...

Home October 15, 2019
News | EP Mapping and Imaging Systems

October 9, 2019 — Acutus Medical and Innovative Health announced a partnership that will offer advanced ...

Home October 09, 2019
News | EP Mapping and Imaging Systems

August 19, 2019 — Scientists at Johns Hopkins have successfully created personalized digital replicas of the upper ...

Home August 19, 2019
News | EP Mapping and Imaging Systems

July 15, 2019 — Acutus Medical announced the publication of the UNCOVER AF study in Circulation: Arrhythmia and ...

Home July 15, 2019
News | EP Mapping and Imaging Systems

July 5, 2019 — Single-use cardiology medical device reprocessing company Innovative Health, received U.S. Food and Drug ...

Home July 05, 2019
Technology | EP Mapping and Imaging Systems

July 1, 2019 — Catheter Precision Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared its new ...

Home July 01, 2019
Subscribe Now